interrupt

The most comprehensive reference database of adherent pain patients.

Provide a new standard of care for your chronic pain patients.

Press Contact

Lon Wagner
757-617-1846
lon.wagner@ameritox.com

Ameritox Press Kit

Ameritox Web Properties

U.S. Headquarters

300 E. Lombard Street
Suite 1610
Baltimore, MD 21202

Midland Laboratory

9930 West Highway 80
Midland, Texas 79706

Greensboro Laboratory

486 Gallimore Dairy Rd
Greensboro, NC 27409

Newsroom

Browse our press releases to get the latest news and information about our company, people and pain medication monitoring solutions^SM. To learn more about Ameritox and the growing importance of urine drug testing in chronic pain care, stop by and see us at an upcoming tradeshow or industry event.

Page:

June 9, 2011
Ameritox: Rx Guardian^SM, with next-generation Rx Guardian CD^SM technology, helps clinicians provide safe, appropriate treatment for chronic pain sufferers
Read Full Release ›
April 25, 2011
Ameritox Hires Regina Morano as New Corporate Compliance Officer and Vice President

Veteran in compliance and ethics will drive continued advancement of compliance program
Read Full Release ›
March 24, 2011
AAPM Symposium Highlights Evolving Landscape of Chronic Opioid Therapy
Read Full Release ›
March 17, 2011
Study of Patients on Chronic Opioid Therapy finds Likely Non-adherent Patients Have Increased Healthcare Costs, More Hospital Days
Read Full Release ›
February 16, 2011
Ameritox Chief Medical Officer to Speak at Hospice and Palliative Care Assembly
Read Full Release ›

Page:

Accreditations:

About Ameritox

Ameritox is the nation's leader in pain medication monitoring, offering urine drug testing services to help physicians assess medication adherence of patients on chronic opioid therapy.

Ameritox Web Properties: rxguardian.ameritox.com | ameritox.monitoringadherence.com | ameritox.populationsatrisk.com

Connect With Ameritox: Ameritox on Twitter | Ameritox on Facebook | Ameritox on YouTube | Ameritox on LinkedIn